CELYAD ONCOLOGY Stock Over 28% Down In The Last 21 Sessions
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) dropped by a staggering 28.24% in 21 sessions from €0.85 to €0.61 at 20:14 EST on Friday, following the last session’s downward trend. BEL 20 is rising 1.67% to €3,799.88, following the last session’s downward trend. About CELYAD ONCOLOGY Celyad Oncology SA, a clinical-stage biopharmaceutical company,…